KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Accured Expenses (2016 - 2025)

Amgen has reported Change in Accured Expenses over the past 17 years, most recently at $579.0 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $579.0 million for Q4 2025, down 1.03% from a year ago — trailing twelve months through Dec 2025 was $499.0 million (up 1078.43% YoY), and the annual figure for FY2025 was $499.0 million, up 1078.43%.
  • Change in Accured Expenses for Q4 2025 was $579.0 million at Amgen, up from -$10.0 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for AMGN hit a ceiling of $804.0 million in Q2 2025 and a floor of -$1.1 billion in Q1 2024.
  • Median Change in Accured Expenses over the past 5 years was -$19.0 million (2023), compared with a mean of -$200000.0.
  • Peak annual rise in Change in Accured Expenses hit 912.5% in 2024, while the deepest fall reached 882.14% in 2024.
  • Amgen's Change in Accured Expenses stood at -$267.0 million in 2021, then plummeted by 141.57% to -$645.0 million in 2022, then soared by 88.84% to -$72.0 million in 2023, then soared by 912.5% to $585.0 million in 2024, then fell by 1.03% to $579.0 million in 2025.
  • The last three reported values for Change in Accured Expenses were $579.0 million (Q4 2025), -$10.0 million (Q3 2025), and $804.0 million (Q2 2025) per Business Quant data.